| 注册
首页|期刊导航|妇儿健康导刊|泼尼松联合氯雷他定治疗小儿过敏性紫癜的临床效果

泼尼松联合氯雷他定治疗小儿过敏性紫癜的临床效果

杨梅

妇儿健康导刊2024,Vol.3Issue(2):49-51,55,4.
妇儿健康导刊2024,Vol.3Issue(2):49-51,55,4.

泼尼松联合氯雷他定治疗小儿过敏性紫癜的临床效果

Clinical effect of Prednisone combined with Loratadine in the treatment of children with hypersensitive purpura

杨梅1

作者信息

  • 1. 山东省淄博市妇幼保健院儿科,山东淄博 255000
  • 折叠

摘要

Abstract

Objective To explore the clinical effect of Prednisone combined with Loratadine in the treatment of children with hypersensitive purpura.Methods A total of 90 children with hypersensitive purpura in Zibo Maternal and Child Health Hospital from October 2021 to October 2022 were selected and divided into control group(45 cases)and study group(45 cases)by the random number table method.The control group received conventional therapy,and the study group received Prednisone combined with Loratadine therapy on the basis of the control group.The efficacy,disease-related indexes and the total incidence of adverse reactions were compared between the two groups.Results The total effective rate of study group was 91.11%,which was higher than 75.56%of control group(P<0.05).After treatment,the leukocyte level,erythrocyte sedimentation rate and serum immunoglobulin A level in the study group were lower than those in the control group(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion Prednisone combined with Loratadine in the treatment of children with hypersensitive purpura has significant clinical effect and high safety,which is worthy of promotion.

关键词

泼尼松/氯雷他定/小儿过敏性紫癜

Key words

Prednisone/Loratadine/Children with hypersensitive purpura

分类

医药卫生

引用本文复制引用

杨梅..泼尼松联合氯雷他定治疗小儿过敏性紫癜的临床效果[J].妇儿健康导刊,2024,3(2):49-51,55,4.

妇儿健康导刊

2097-115X

访问量0
|
下载量0
段落导航相关论文